158 related articles for article (PubMed ID: 34861944)
1. DNA polymerases of herpesviruses and their inhibitors.
Piret J; Boivin G
Enzymes; 2021; 50():79-132. PubMed ID: 34861944
[TBL] [Abstract][Full Text] [Related]
2. Herpesvirus DNA polymerases: Structures, functions and inhibitors.
Zarrouk K; Piret J; Boivin G
Virus Res; 2017 Apr; 234():177-192. PubMed ID: 28153606
[TBL] [Abstract][Full Text] [Related]
3. Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.
DiScipio KA; Weerasooriya S; Szczepaniak R; Hazeen A; Wright LR; Wright DL; Weller SK
mBio; 2022 Feb; 13(1):e0322621. PubMed ID: 35073739
[TBL] [Abstract][Full Text] [Related]
4. Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.
Chen H; Lawler JL; Filman DJ; Hogle JM; Coen DM
mBio; 2021 Feb; 12(1):. PubMed ID: 33563814
[TBL] [Abstract][Full Text] [Related]
5. Testing the susceptibility of human herpesviruses to antivirals.
Agut H; Boutolleau D; Deback C; Bonnafous P; Gautheret-Dejean A
Future Microbiol; 2009 Nov; 4(9):1111-23. PubMed ID: 19895215
[TBL] [Abstract][Full Text] [Related]
6. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
7. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
Magee WC; Evans DH
Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of ganciclovir-induced chain termination revealed by resistant viral polymerase mutants with reduced exonuclease activity.
Chen H; Beardsley GP; Coen DM
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17462-7. PubMed ID: 25422422
[TBL] [Abstract][Full Text] [Related]
9. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.
Gilbert C; Bestman-Smith J; Boivin G
Drug Resist Updat; 2002 Apr; 5(2):88-114. PubMed ID: 12135584
[TBL] [Abstract][Full Text] [Related]
10. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R
J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713
[TBL] [Abstract][Full Text] [Related]
11. Development of new antivirals for herpesviruses.
Eizuru Y
Antivir Chem Chemother; 2003 Nov; 14(6):299-308. PubMed ID: 14968936
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
Coen DM; Fleming HE; Leslie LK; Retondo MJ
J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
[TBL] [Abstract][Full Text] [Related]
13. Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase.
Topalis D; Gillemot S; Snoeck R; Andrei G
Nucleic Acids Res; 2016 Nov; 44(20):9530-9554. PubMed ID: 27694307
[TBL] [Abstract][Full Text] [Related]
14. The enzymological basis for resistance of herpesvirus DNA polymerase mutants to acyclovir: relationship to the structure of alpha-like DNA polymerases.
Huang L; Ishii KK; Zuccola H; Gehring AM; Hwang CB; Hogle J; Coen DM
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):447-52. PubMed ID: 9892653
[TBL] [Abstract][Full Text] [Related]
15. Excision of nucleoside analogs in mitochondria by p53 protein.
Bakhanashvili M; Grinberg S; Bonda E; Rahav G
AIDS; 2009 Apr; 23(7):779-88. PubMed ID: 19287302
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.
Gammon DB; Snoeck R; Fiten P; Krecmerová M; Holý A; De Clercq E; Opdenakker G; Evans DH; Andrei G
J Virol; 2008 Dec; 82(24):12520-34. PubMed ID: 18842735
[TBL] [Abstract][Full Text] [Related]
17. Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymerase.
Hayes RP; Heo MR; Mason M; Reid J; Burlein C; Armacost KA; Tellers DM; Raheem I; Shaw AW; Murray E; McKenna PM; Abeywickrema P; Sharma S; Soisson SM; Klein D
Nat Commun; 2021 May; 12(1):3040. PubMed ID: 34031403
[TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
[TBL] [Abstract][Full Text] [Related]
19. Antiviral Drugs Against Herpesviruses.
Piret J; Boivin G
Adv Exp Med Biol; 2021; 1322():1-30. PubMed ID: 34258735
[TBL] [Abstract][Full Text] [Related]
20. Hinge Region in DNA Packaging Terminase pUL15 of Herpes Simplex Virus: A Potential Allosteric Target for Antiviral Drugs.
Thaljeh LF; Rothschild JA; Naderi M; Coghill LM; Brown JM; Brylinski M
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
